Discovery of Clinical Candidate 2-((2<i>S</i>,6<i>S</i>)-2-Phenyl-6-hydroxyadamantan-2-yl)-1-(3′-hydroxyazetidin-1-yl)ethanone [BMS-816336], an Orally Active Novel Selective 11β-Hydroxysteroid Dehydrogenase Type 1 InhibitorXiang‐Yang Ye, Jeffrey A. Robl, Stephen P. O’Connor et al.|Journal of Medicinal Chemistry|2017Cited by 18
Synthesis and structure–activity relationship of 2-adamantylmethyl tetrazoles as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1)Xiang‐Yang Ye, Jeffrey A. Robl, David Yoon et al.|Bioorganic & Medicinal Chemistry Letters|2013Cited by 17
Design, synthesis, and SAR studies of novel polycyclic acids as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1)Xiang‐Yang Ye, Jeffrey A. Robl, Stephanie Chen et al.|Bioorganic & Medicinal Chemistry Letters|2011Cited by 12